[ RadSafe ] " House Committee Passes Bill to Create US Isotope Supply "
frantaj at aecl.ca
Mon Oct 26 11:05:15 CDT 2009
UNRESTRICTED | ILLIMITÉ
Gee..... one wonders why they didn't simply keep FFTF in operation - retasked to meds production ??
House Committee Passes Bill to Create US Isotope Supply
Device & Diagnostic Letter
Vol. 36, No. 42
26 October 2009
To head off future shortages of the most commonly used diagnostic radioisotope, a House committee has passed a bill to create a steady domestic supply of molybdenum-99 (Mo-99).
The American Medical Isotopes Production Act, H.R. 3276, gives the Energy Department the authority and funding to help the private sector establish a U.S. supply of Mo-99 without using highly enriched uranium, according to a statement from the House Energy and Commerce Committee.
If passed, the House bill could help advance two private projects already in the works, Matmuller said, as it includes a $163 million provision to support domestic production of the isotope (D&DL, Sept. 14).
In February, Covidien signed an agreement with Babcock & Wilcox to develop technology to manufacture Mo-99 in the U.S. When complete, the collaboration could supply more than 50 percent of the U.S. demand for the radioisotope (D&DL, Feb. 2). Last year, Advanced Medical Isotope signed an agreement with the University of Missouri Research Reactor Center to develop the isotope.
Neither of these projects has applied to formally begin the regulatory approval process, Robert Lewis, director of NRC's Division of Materials Safety and State Agreements, said.
In related news, the NRC also has noticed a shortage of another prominent medical isotope, iodine-131, Matmuller said.
CONFIDENTIAL AND PRIVILEGED INFORMATION NOTICE
This e-mail, and any attachments, may contain information that
is confidential, subject to copyright, or exempt from disclosure.
Any unauthorized review, disclosure, retransmission,
dissemination or other use of or reliance on this information
may be unlawful and is strictly prohibited.
AVIS D'INFORMATION CONFIDENTIELLE ET PRIVILÉGIÉE
Le présent courriel, et toute pièce jointe, peut contenir de
l'information qui est confidentielle, régie par les droits
d'auteur, ou interdite de divulgation. Tout examen,
divulgation, retransmission, diffusion ou autres utilisations
non autorisées de l'information ou dépendance non autorisée
envers celle-ci peut être illégale et est strictement interdite.
More information about the RadSafe